Neurocognitive effects of subanesthetic serial ketamine infusions in treatment resistant depression.
Journal of Affective Disorders April 1, 2023 Artemis Zavaliangos-Petropulu, Shawn M. Mcclintock, Jacqueline Khalil et al. 16 citations
INTRODUCTION Ketamine treatment prompts a rapid antidepressant response in treatment-resistant depression (TRD). We performed an exploratory investigation of how ketamine treatment in TRD affects different cognitive domains and relates to antidepressant response. METHODS Patients with TRD (N = 66; 30 M/35F; age = 39.5 ± 11.1 years) received four ketamine infusions (0.5 mg/kg). Neurocognitive...